LifeTech Scientific Corporation (HKG:1302)

Market Cap	7.69B +5.1%
Revenue (ttm)	1.52B +5.1%
Net Income	164.50M -33.5%
EPS	0.04 -35.0%
Shares Out	4.63B
PE Ratio	45.20
Forward PE	14.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,552,000
Open	1.710
Previous Close	1.720
Day's Range	1.630 - 1.750
52-Week Range	1.470 - 2.440
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,245
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2025, LifeTech Scientific's revenue was 1.37 billion, an increase of 5.07% compared to the previous year's 1.30 billion. Earnings were 147.83 million, a decrease of -33.53%.

Financial numbers in CNY